Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 5
2005 5
2006 4
2007 7
2008 3
2009 5
2010 9
2011 11
2012 14
2013 4
2014 14
2015 9
2016 9
2017 8
2018 17
2019 18
2020 22
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

155 results
Results by year
Filters applied: . Clear all
Page 1
Direct Targeting Options for STAT3 and STAT5 in Cancer.
Orlova A, Wagner C, de Araujo ED, Bajusz D, Neubauer HA, Herling M, Gunning PT, Keserű GM, Moriggl R. Orlova A, et al. Among authors: keseru gm. Cancers (Basel). 2019 Dec 3;11(12):1930. doi: 10.3390/cancers11121930. Cancers (Basel). 2019. PMID: 31817042 Free PMC article. Review.
Pharmacologic inhibition of STAT5 in acute myeloid leukemia.
Wingelhofer B, Maurer B, Heyes EC, Cumaraswamy AA, Berger-Becvar A, de Araujo ED, Orlova A, Freund P, Ruge F, Park J, Tin G, Ahmar S, Lardeau CH, Sadovnik I, Bajusz D, Keserű GM, Grebien F, Kubicek S, Valent P, Gunning PT, Moriggl R. Wingelhofer B, et al. Leukemia. 2018 May;32(5):1135-1146. doi: 10.1038/s41375-017-0005-9. Epub 2018 Feb 2. Leukemia. 2018. PMID: 29472718 Free PMC article.
The role of ligand efficiency metrics in drug discovery.
Hopkins AL, Keserü GM, Leeson PD, Rees DC, Reynolds CH. Hopkins AL, et al. Among authors: keseru gm. Nat Rev Drug Discov. 2014 Feb;13(2):105-21. doi: 10.1038/nrd4163. Nat Rev Drug Discov. 2014. PMID: 24481311 Review.
Targeting STAT3 and STAT5 in Cancer.
de Araujo ED, Keserű GM, Gunning PT, Moriggl R. de Araujo ED, et al. Among authors: keseru gm. Cancers (Basel). 2020 Jul 22;12(8):2002. doi: 10.3390/cancers12082002. Cancers (Basel). 2020. PMID: 32707820 Free PMC article.
Covalent fragment libraries in drug discovery.
Keeley A, Petri L, Ábrányi-Balogh P, Keserű GM. Keeley A, et al. Among authors: keseru gm. Drug Discov Today. 2020 Jun;25(6):983-996. doi: 10.1016/j.drudis.2020.03.016. Epub 2020 Apr 13. Drug Discov Today. 2020. PMID: 32298798 Free article. Review.
Allosteric Molecular Switches in Metabotropic Glutamate Receptors.
Orgován Z, Ferenczy GG, Keserű GM. Orgován Z, et al. Among authors: keseru gm. ChemMedChem. 2021 Jan 8;16(1):81-93. doi: 10.1002/cmdc.202000444. Epub 2020 Aug 25. ChemMedChem. 2021. PMID: 32686363 Review.
Expanding the medicinal chemistry synthetic toolbox.
Boström J, Brown DG, Young RJ, Keserü GM. Boström J, et al. Among authors: keseru gm. Nat Rev Drug Discov. 2018 Oct;17(10):709-727. doi: 10.1038/nrd.2018.116. Epub 2018 Aug 24. Nat Rev Drug Discov. 2018. PMID: 30140018 Review.
Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators.
Orgován Z, Ferenczy GG, Keserű GM. Orgován Z, et al. Among authors: keseru gm. Curr Top Med Chem. 2019;19(19):1768-1781. doi: 10.2174/1568026619666190808150039. Curr Top Med Chem. 2019. PMID: 31393248 Review.
Small molecule inhibitors of RAS proteins with oncogenic mutations.
Orgován Z, Keserű GM. Orgován Z, et al. Among authors: keseru gm. Cancer Metastasis Rev. 2020 Dec;39(4):1107-1126. doi: 10.1007/s10555-020-09911-9. Cancer Metastasis Rev. 2020. PMID: 32770300 Free PMC article. Review.
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.
de Araujo ED, Orlova A, Neubauer HA, Bajusz D, Seo HS, Dhe-Paganon S, Keserű GM, Moriggl R, Gunning PT. de Araujo ED, et al. Among authors: keseru gm. Cancers (Basel). 2019 Nov 8;11(11):1757. doi: 10.3390/cancers11111757. Cancers (Basel). 2019. PMID: 31717342 Free PMC article. Review.
155 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback